Of note, loss of GIT1 in ER− breast cancer tumors increased Notch signaling and the cancer stem cell pool (Zhang et al., 2022), reflecting the phenotype of increased PKD3 expression (Lieb et al., 2020). This evidence concerns the gene PRKD3 and breast cancer.